14 Mar Fosun Pharma joins Shenzhen government to raise US$700 million healthcare fund to invest in biomedicine innovation
Posted at 11:00h
in Asia
One of China’s biggest pharmaceutical producers will team up with Shenzhen’s government to raise a 5-billion yuan (US$700 million) healthcare fund to invest in start-ups and innovations in cellular biology, genetics and other fields related to biomedicine.Fosun Pharma said its subsidiaries, namely Fuxin Shenyao, Fosun...